Rezafungin is non-inferior to caspofungin in the treatment of candidemia and invasive candidiasis
1. Global cure was achieved in 59% of the rezafungin group compared to 61% of the caspofungin...
Jan 27, 2023
1. Global cure was achieved in 59% of the rezafungin group compared to 61% of the caspofungin...
Jan 27, 2023
1. Individuals with more severe acute COVID-19 illness and an unvaccinated status prior to...
Jan 27, 2023
1. In a randomized clinical trial, internet-delivered parent-child interaction therapy (iPCIT)...
Jan 27, 2023
1. In a case-control study, a diagnostic prediction tool was able to identify cerebral palsy with...
Jan 27, 2023
1. Empagliflozin led to a lower risk of kidney disease progression in patients with chronic kidney...
Jan 27, 2023
1. Patients with chronic obstructive pulmonary disease (COPD) had lower survival rates and greater...
Jan 27, 2023
Overall tumour response to monotherapy treatment with adagrasib was 23% 46% in combination with...
Jan 27, 2023
1. In this prospective cohort study, greater consumption of healthful plant-based foods was...
Jan 27, 2023
1. A dominant deep-intron GAA repeat expansion in the FGF14 gene was found among French Canadian...
Jan 27, 2023
1. In patients with untreated paroxysmal atrial fibrillation, catheter ablation was associated...
Jan 27, 2023
1. In this randomized clinical trial, there were no differences in mortality, pulmonary embolism,...
Jan 27, 2023
1. In a cluster-randomized trial of a community-based program adults living in public housing in...